Use of 4 - (2 - ethyl - 3.6 propoxy) - dimethyl - 2 - (2,4,6 - trimethyl - (phenoxy) pyridine or 3.6 - dimethyl - 2 - (2,4,6 - trimethyl - phenoxy) - (pyridin-4-yl) - (1 - Ethyl propyl) amineUnprofarmaco of the same or a pharmaceutically acceptable Salt or prodrug thereof for the preparation of a Medicament for the Treatment

摘要

1. Treatment of heart failure in mammals by drug formulation, including 4 - (1-ethyl-propoxi) - 3,6-dimethyl-2 - (2,4,6-trimethyl-phenyl) - pyridine and (3,6-dimethyl-2 - (2,4), 6-trimethylphenyl-pyridine-4-il - (1-ethyl-propyl) - amine or pharmaceutically acceptable saltIt's all the same It is used to prepare a mixture of these two mediums and other mediums for the treatment of congestive heart failure. Composers and a team of composers